199 related articles for article (PubMed ID: 31387890)
1. LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P.
You Z; Liu C; Wang C; Ling Z; Wang Y; Wang Y; Zhang M; Chen S; Xu B; Guan H; Chen M
Mol Cancer Ther; 2019 Dec; 18(12):2469-2479. PubMed ID: 31387890
[TBL] [Abstract][Full Text] [Related]
2. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.
Chen L; Hu N; Wang C; Zhao H; Gu Y
Cell Cycle; 2018; 17(3):319-329. PubMed ID: 29228867
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT1/miR-148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization.
Liu J; Ding D; Jiang Z; Du T; Liu J; Kong Z
Prostate; 2019 Jan; 79(1):105-112. PubMed ID: 30221381
[TBL] [Abstract][Full Text] [Related]
5. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract][Full Text] [Related]
8. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.
Huang K; Tang Y
Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
[TBL] [Abstract][Full Text] [Related]
9. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
10. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
11. lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.
Cui B; Li B; Liu Q; Cui Y
J Cell Biochem; 2017 Dec; 118(12):4548-4557. PubMed ID: 28475287
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.
Ma MZ; Chu BF; Zhang Y; Weng MZ; Qin YY; Gong W; Quan ZW
Cell Death Dis; 2015 Jan; 6(1):e1583. PubMed ID: 25569100
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.
Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F
Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging miR-181 in hepatocellular carcinoma.
Guo J; Ma Y; Peng X; Jin H; Liu J
J Cell Biochem; 2019 Oct; 120(10):17975-17983. PubMed ID: 31218739
[TBL] [Abstract][Full Text] [Related]
17. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
Li Y; Zhu G; Ma Y; Qu H
J Cell Biochem; 2019 Dec; 120(12):19457-19468. PubMed ID: 31478245
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CCAT1 promotes the migration and invasion of prostate cancer PC-3 cells.
Chen H; He Y; Hou YS; Chen DQ; He SL; Cao YF; Wu XM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2991-2996. PubMed ID: 29863242
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
20. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
Lai XJ; Cheng HF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
